Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: Current concepts

Clinics in Perinatology

Volumn 29, Issue 4, 2002, Pages 585-602

  Grow, Jennifer ^a   Barks, John D E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; EXCITATORY AMINO ACID; FREE RADICAL; INTERLEUKIN 1BETA; LIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

APOPTOSIS; BRAIN DEVELOPMENT; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; ENERGY RESOURCE; GENETIC SUSCEPTIBILITY; HUMAN; MATERNAL DISEASE; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NEWBORN INFECTION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; BIRTH INJURIES; BRAIN CHEMISTRY; CALCIUM; CYTOKINES; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACIDS; FREE RADICALS; HUMANS; HYPOTHERMIA, INDUCED; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; OLIGODENDROGLIA; RISK FACTORS;

EID: 0036945725     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(02)00059-3     Document Type: Review

References (129)

1. Roohey T, Raju TN, Moustogiannis AN. Animal models for the study of perinatal hypoxicischemic encephalopathy: A critical analysis. Early Hum Dev 1997;47:115-46.
2. Vannucci RC, Vannucci SJ. Glucose, acidosis and perinatal hypoxic-ischemic brain damage. Ment Retard Dev Disabil Res Rev 1997;3:69-75.
3. Sheldon RA, Sedik C, Ferriero DM. Strain-related brain injury in neonatal mice subjected to hypoxia-ischemia. Brain Res 1998;810:114-22.
4. Jensen FE, Applegate CD, Holtzman D, et al. Epileptogenic effect of hypoxia in the immature rodent brain. Ann Neurol 1991;29:629-37.
5. Ment LR, Schwartz M, Makuch RW, et al. Association of chronic sublethal hypoxia with ventriculomegaly in the developing rat brain. Brain Res Dev Brain Res 1998;111:197-203.
6. Mujsce DJ, Christensen MA, Vannucci RC. Cerebral blood flow and edema in perinatal hypoxic-ischemic brain damage. Pediatr Res 1990;27:450-3.
7. Laptook AR, Corbett RJ, Nguyen HT, et al. Alterations in cerebral blood flow and phosphorylated metabolites in piglets during and after partial ischemia. Pediatr Res 1988;23:206-11.
8. Yager JY, Brucklacher RM, Vannucci RC. Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am J Physiol 1992;262:H672-7.
9. Younkin DP, Wagerle LC, Chance B, et al. 31P-NMR studies of cerebral metabolic changes during graded hypoxia in newborn lambs. J Appl Physiol 1987;62:1569-74.
10. Hope PL, Costello AM, Cady EB, et al. Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet 1984;2:366-70.
11. Lorek A, Takei Y, Cady EB, et al. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: Continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res 1994;36:699-706.
12. Hanrahan JD, Cox IJ, Azzopardi D, et al. Relation between proton magnetic resonance spectroscopy within 18 hours of birth asphyxia and neurodevelopment at 1 year of age. Dev Med Child Neurol 1999;41:76-82.
13. Roth SC, Edwards AD, Cady EB, et al. Relation between cerebral oxidative metabolism following birth asphyxia, and neurodevelopmental outcome and brain growth at one year. Dev Med Child Neurol 1992;34:285-95.
14. Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol 2000;13:133-9.
15. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001;2:734-44.
16. Grether JK, Nelson KB, Dambrosia JM, et al. Interferons and cerebral palsy. J Pediatr 1999;134:324-32.
17. Nelson KB, Dambrosia JM, Grether JK, et al. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665-75.
18. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19-26.
19. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001;13:1101-6.
20. Johnston MV. Excitotoxicity in neonatal hypoxia. Ment Retard Dev Disabil Res Rev 2001;7:229-34.
21. Follett PL, Rosenberg PA, Volpe JJ, et al. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20:9235-41.
22. Silverstein FS, Naik B, Simpson J. Hypoxia-ischemia stimulates hippocampal glutamate efflux in perinatal rat brain - An in vivo microdialysis study. Pediatr Res 1991;30:587-90.
23. Thoresen M, Satas S, Puka-Sundvall M, et al. Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins. Neuroreport 1997;8:3359-62.
24. Hagberg H, Thornberg E, Blennow M, et al. Excitatory amino acids in the cerebrospinal fluid of asphyxiated infants: Relationship to hypoxic-ischemic encephalopathy. Acta Paediatr 1993;82:925-9.
25. Silverstein FS, Buchanan K, Johnston MV. Perinatal hypoxia-ischemia disrupts striatal high-affinity [3H]glutamate uptake into synaptosomes. J Neurochem 1986;47:1614-9.
26. Gilland E, Puka-Sundvall M, Andine P, et al. Hypoxic-ischemic injury in the neonatal rat brain: Effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87. Brain Res Dev Brain Res 1994;83:79-84.
27. Cai Z, Xiao F, Fratkin JD, et al. Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a Group II metabotropic glutamate receptor agonist. Neuroreport 1999;10:3927-31.
28. Hagberg H, Gilland E, Diemer N-H, et al. Hypoxia-ischemia in the neonatal rat brain: Histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol Neonate 1994;66:205-13.
29. McDonald JW, Silverstein FS, Johnston MV. MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol 1987;140:359-61.
30. McDonald JW, Silverstein FS, Johnston MV. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 1988;459:200-3.
31. McDonald JW, Trescher WH, Johnston MV. Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res 1992;583:54-70.
32. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke 1998;29:705-18.
33. Puka-Sundvall M, Gajkowska B, Cholewinski M, et al. Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats. Brain Res Dev Brain Res 2000;125:31-41.
34. Vannucci RC, Brucklacher RM, Vannucci SJ. Intracellular calcium accumulation during the evolution of hypoxic-ischemic brain damage in the immature rat. Brain Res Dev Brain Res 2001;126:117-20.
35. Blomgren K, Hallin U, Andersson AL, et al. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J Biol Chem 1999;274:14046-52.
36. Blomgren K, McRae A, Bona E, et al. Degradation of fodrin and MAP 2 after neonatal cerebral hypoxic-ischemia. Brain Res 1995;684:136-42.
37. Walton M, Sirimanne E, Williams C, et al. Prostaglandin H synthase-2 and cytosolic phospholipase A2 in the hypoxic-ischemic brain: Role in neuronal death or survival? Brain Res Mol Brain Res 1997;50:165-70.
38. Gunn AJ, Williams CE, Mallard EC, et al. Flunarizine, a calcium channel antagonist, is partially prophylactically neuroprotective in hypoxic-ischemic encephalopathy in the fetal sheep. Pediatr Res 1994;35:657-63.
39. Silverstein FS, Buchanan K, Hudson C, et al. Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke 1986;17:477-82.
40. Levene MI, Gibson NA, Fenton AC, et al. The use of a calcium-channel blocker, nicardipine, for severely asphyxiated newborn infants. Dev Med Child Neurol 1990;32:567-74.
41. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001;21:2-14.
42. Fullerton HJ, Ditelberg JS, Chen SF, et al. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 1998;44:357-64.
43. Roskams AJ, Connor JR. Iron, transferrin, and ferritin in the rat brain during development and aging. J Neurochem 1994;63:709-16.
44. Armstead WM, Mirro R, Busija DW, et al. Postischemic generation of superoxide anion by newborn pig brain. Am J Physiol 1988;255:H401-3.
45. Bagenholm R, Nilsson UA, Gotborg CW, et al. Free radicals are formed in the brain of fetal sheep during reperfusion after cerebral ischemia. Pediatr Res 1998;43:271-5.
46. Palmer C, Roberts RL, Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 1994;25:1039-45.
47. Palmer C, Towfighi J, Roberts RL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr Res 1993;33:405-11.
48. Perlman JM, Risser R. Relationship of uric acid concentrations and severe intraventricular hemorrhage/leukomalacia in the premature infant. J Pediatr 1998;132:436-9.
49. Van Bel F, Shadid M, Moison RM, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185-93.
50. Clancy RR, McGaurn SA, Goin JE, et al. Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001;108:61-70.
51. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
52. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132-9.
53. Black SM, Bedolli MA, Martinez S, et al. Expression of neuronal nitric oxide synthase corresponds to regions of selective vulnerability to hypoxia-ischaemia in the developing rat brain. Neurobiol Dis 1995;2:145-55.
54. Higuchi Y, Hattori H, Kume T, et al. Increase in nitric oxide in the hypoxic-ischemic neonatal rat brain and suppression by 7-nitroindazole and aminoguanidine. Eur J Pharmacol 1998;342:47-9.
55. Ikeno S, Nagata N, Yoshida S, et al. Immature brain injury via peroxynitrite production induced by inducible nitric oxide synthase after hypoxia-ischemia in rats. J Obstet Gynaecol Res 2000; 26:227-34.
56. Tsuji M, Higuchi Y, Shiraishi K, et al. Protective effect ofaminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr Res 2000; 47:79-83.
57. Hamada Y, Hayakawa T, Hattori H, et al. Inhibitor of nitric oxide synthesis reduces hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 1994;35:10-4.
58. Ishida A, Trescher WH, Lange MS, et al. Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 2001;23:349-54.
59. Trifiletti RR. Neuroprotective effects of N(G)-nitro-L-arginine in focal stroke in the 7-day old rat. Eur J Pharmacol 1992;218:197-8.
60. Ferriero DM, Holtzman DM, Black SM, et al. Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 1996;3:64-71.
61. Shi Y, Pan F, Li H, et al. Role of carbon monoxide and nitric oxide in newborn infants with postasphyxial hypoxic-ischemic encephalopathy. Pediatrics 2000;106:1447-51.
62. Cammer W. Effects of TNFalpha on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res 2000;864:213-9.
63. Cheng B, Christakos S, Mattson MP. Tumor necrosis factors protect neurons against metabolicexcitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994;12:139-53.
64. Savman K, Blennow M, Gustafson K, et al. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res 1998;43:746-51.
65. Deguchi K, Mizuguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia. Pediatr Neurol 1996;14:13-6.
66. Yoon BH, Romero R, Kim CJ, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-11.
67. Hagberg H, Gilland E, Bona E, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996; 40:603-9.
68. Szaflarski J, Burtrum D, Silverstein FS. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats. Stroke 1995;26:1093-100.
69. Martin D, Chinookoswong N, Miller G. The interleukin-I receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol 1994;130:362-7.
70. Liu XH, Kwon D, Schielke GP, et al. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 1999;19:1099-108.
71. Ivacko JA, Sun R, Silverstein FS. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res 1996;39:39-47.
72. Eun BL, Liu XH, Barks JD. Pentoxifylline attenuates hypoxic-ischemic brain injury in immature rats. Pediatr Res 2000;47:73-8.
73. Bona E, Andersson AL, Blomgren K, et al. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999;45:500-9.
74. Cowell RM, Xu H, Galasso JM, et al. Hypoxic-ischemic injury induces macrophage inflammatory protein-1α expression in immature rat brain. Stroke 2002;33:795-801.
75. Ivacko J, Szaflarski J, Malinak C, et al. Hypoxic-ischemic injury induces monocyte chemo-attractant protein-1 expression in neonatal rat brain. J Cereb Blood Flow Metab 1997;17:759-70.
76. Hudome S, Palmer C, Roberts RL, et al. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 1997;41:607-16.
77. Doucet JP, Bazan NG. Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma. Mol Neurobiol 1992;6:407-24.
78. Bishai I, Coceani F. Eicosanoid formation in the rat cerebral cortex. Contribution of neurons and glia. Mol Chem Neuropathol 1992;17:219-38.
79. Coceani F, Akarsu ES. Prostaglandin E2 in the pathogenesis of fever. An update. Ann N Y Acad Sci 1998;856:76-82.
80. Sapirstein A, Bonventre JV. Phospholipases A2 in ischemic and toxic brain injury. Neurochem Res 2000;25:745-53.
81. Iadecola C, Niwa K, Nogawa S, et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 2001;98:1294-9.
82. Rogers MS, Wang W, Mongelli M, et al. Lipid peroxidation in cord blood at birth: A marker of fetal hypoxia during labour. Gynecol Obstet Invest 1997;44:229-33.
83. Schmidt H, Grune T, Muller R, et al. Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr Res 1996;40:15-20.
84. Akisu M, Kultursay N, Coker I, et al. Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: Is it an additional marker of perinatal asphyxia? Acta Paediatr Jpn 1998;40:427-31.
85. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-72.
86. Tong H, Richards E, Wood CE. Prostaglandin endoperoxide synthase-2 abundance is increased in brain tissues of late-gestation fetal sheep in response to cerebral hypoperfusion. J Soc Gynecol Investig 1999;6:127-35.
87. Bagenholm R, Nilsson UA, Kjellmer I. Formation of free radicals in hypoxic ischemic brain damage in the neonatal rat, assessed by an endogenous spin trap and lipid peroxidation. Brain Res 1997;773:132-8.
88. Bagenholm R, Andine P, Hagberg H. Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat. Pediatr Res 1996;40:399-403.
89. Akisu M, Kultursay N, Coker I, et al. Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate 1998;74:439-44.
90. Liu XH, Eun BL, Barks JDE. Platelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 2001;49:804-11.
91. Liu XH, Eun BL, Silverstein FS, et al. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res 1996;40:797-803.
92. Rorke LB. Pathology of Perinatal Brain Injury. New York: Raven Press; 1982.
93. Takashima S, Tanaka K. Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol 1978;35:11-6.
94. Back SA, Volpe JJ. Cellular and molecular pathogenesis of periventricular white matter injury. Ment Retard Dev Disab Res Rev 1997;3:96-107.
95. Back SA, Luo NL, Borenstein NS, et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001; 21:1302-12.
96. Inder TE, Huppi PS, Warfield S, et al. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 1999; 46:755-60.
97. Back SA, Han BH, Luo NL, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002;22:455-63.
98. Ikeda T, Murata Y, Quilligan EJ, et al. Physiologic and histologic changes in near-term fetal lambs exposed to asphyxia by partial umbilical cord occlusion. Am J Obstet Gynecol 1998;178:24-32.
99. Liu YQ, Silverstein FS, Skoff R, et al. Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatr Res 2002;51:25-33.
100. Yue X, Mehmet H, Penrice J, et al. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischaemia. Neuropathol Appl Neurobiol 1997;23:16-25.
101. Skoff RP, Bessert DA, Barks JD, et al, Hypoxic-ischemic injury results in acute disruption of myelin gene expression and death of oligodendroglial precursors in neonatal mice. Int J Dev Neurosci 2001;19:197-208.
102. Ness JK, Romanko MJ, Rothstein RP, et al. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors, Dev Neurosci 2001;23:203-8.
103. Levison SW, Rothstein RP, Romanko MJ, et al. Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev Neurosci 2001;23:234-47.
104. Oka A, Belliveau MJ, Rosenberg PA, et al. Vulnerability of oligodendroglia to glutamate - Pharmacology, mechanisms, and prevention. J Neurosci 1993;13:1441-53.
105. Back SA, Gan X, Li Y, et al. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998;18:6241-53.
106. Baerwald KD, Popko B. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J Neurosci Res 1998;52:230-9.
107. Young RS, Yagel SK, Towfighi J. Systemic and neuropathologic effects of E. coli endotoxin in neonatal dogs. Pediatr Res 1983;17:349-53.
108. Edwards AD, Yue X, Cox P, et al. Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatr Res 1997;42:684-9.
109. Nakajima W, Ishida A, Lange MS, et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 2000;20:7994-8004.
110. Northington FJ, Ferriero DM, Graham EM, et al. Early neurodegeneration after hypoxia-ischemia in neonatal rat is necrosis while delayed neuronal death is apoptosis. Neurobiol Dis 2001;8:207-19.
111. Hu BR, Liu CL, Ouyang Y, et al. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 2000;20:1294-300.
112. Sidhu RS, Tuor UI, Del Bigio MR. Nuclear condensation and fragmentation following cerebral hypoxia-ischemia occurs more frequently in immature than older rats. Neurosci Lett 1997;223:129-32.
113. Green DR. Apoptotic pathways: Paper wraps stone blunts scissors. Cell 2000;102:1-4.
114. Adams JM, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science 1998;281:1322-6.
115. Noshita N, Sugawara T, Fujimura M, et al. Manganese superoxide dismutase affects cytochrome c release and caspase-9 activation after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2001;21:557-67.
116. Nicholson DW. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999;6:1028-42.
117. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998;101:1992-9.
118. Pulera MR, Adams LM, Liu H, et al. Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke 1998;29:2622-30.
119. Wang X, Karlsson JO, Zhu C, et al. Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia. Biol Neonate 2001;79:172-9.
120. Parsadanian AS, Cheng Y, Keller-Peck CR, et al. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 1998;18:1009-19.
121. Gunn AJ. Cerebral hypothermia for prevention of brain injury following perinatal asphyxia. Curr Opin Pediatr 2000;12:111-5.
122. Nedelcu J, Klein MA, Aguzzi A, et al. Resuscitative hypothermia protects the neonatal rat brain from hypoxic-ischemic injury. Brain Pathol 2000;10:61-71.
123. Thoresen M, Penrice J, Lorek A, et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res 1995;37:667-70.
124. Edwards AD, Yue X, Squier MV, et al. Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia. Biochem Biophys Res Commun 1995;217:1193-9.
125. Fukuda H, Tomimatsu T, Watanabe N, et al. Post-ischemic hypothermia blocks caspase-3 activation in the newborn rat brain after hypoxia-ischemia. Brain Res 2001;910:187-91.
126. Abraham H, Lazar G. Early microglial reaction following mild forebrain ischemia induced by common carotid artery occlusion in rats. Brain Res 2000;862:63-73.
127. Goss JR, Styren SD, Miller PD, et al. Hypothermia attenuates the normal increase in interleukin 1β RNA and nerve growth factor following traumatic brain injury in the rat. J Neurotrauma 1995;12:159-67.
128. Patel PM, Drummond JC, Cole DJ, et al. Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats. Brain Res 1994;650:205-11.
129. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000;20:5775-81.